<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04812782</url>
  </required_header>
  <id_info>
    <org_study_id>Dietary Fat in Type 1 Diabetes</org_study_id>
    <nct_id>NCT04812782</nct_id>
  </id_info>
  <brief_title>Dietary Fat and Endothelial Function in Type 1 Diabetes</brief_title>
  <official_title>Influence Of Extra Virgin Olive Oil and Butter on Endothelial Function in Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of the add-on of extra vergin olive oil&#xD;
      or butter to a high glycemic index meal on endothelial function in subjects with type 1&#xD;
      Diabetes and healthy subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Impaired endothelial function is an early manifestation of atherosclerosis and predictor of&#xD;
      incident cardiovascular events. Diabetes affects arterial vasodilation by reducing the&#xD;
      bioavailability of NO and more in general affecting the balance between the atheroprotective&#xD;
      and atherothrombotic properties of the endothelium. A consistent number of studies has so far&#xD;
      documented that Mediterranean-style diet associates with reduced risk of cardiovascular&#xD;
      diseases and diabetes. Intake of extra virgin olive oil (EVOO), that is a common but not&#xD;
      necessary ingredient of the Mediterranean diet, seems to further enhance the beneficial&#xD;
      cardiovascular effect and reduce the incidence of diabetes. We have designed the present&#xD;
      study to test whether EVOO supplementation acutely influences endothelial function in T1DM.&#xD;
      EVOO supplementation wil be compared to butter supplementation in the context of a high&#xD;
      glycemic index (GI) meal that is known to increase PP glycemic burden.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2018</start_date>
  <completion_date type="Actual">October 16, 2019</completion_date>
  <primary_completion_date type="Actual">October 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Cross-over, interventional, controlled study.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Endothelial function from pre meal to post meal period</measure>
    <time_frame>before meal, 1 hour, 3 hour, 5 hour after meal</time_frame>
    <description>Flow mediated dilation technique by ultrasound</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum glucose</measure>
    <time_frame>before meal, 1 hour, 2 hour, 3 hour, 4 hour, 5 hour after meal</time_frame>
    <description>glucose-hexokinase method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastric emptying rate</measure>
    <time_frame>before meal, 15, 90, 120, 180, 240, 300 minutes after meal</time_frame>
    <description>Ultrasound antrum measurement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>EVOO-Butter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with EVOO and the second with butter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Butter-EVOO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients and control subjects who met inclusion and exclusion criteria, and signed the Informed Consent, were scheduled for the two study visits, one week apart, during which each participant received two types of high GI meal: the first enriched with Butter and the second with EVOO</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EVOO supplementation</intervention_name>
    <description>We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with EVOO</description>
    <arm_group_label>Butter-EVOO</arm_group_label>
    <arm_group_label>EVOO-Butter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Butter supplementation</intervention_name>
    <description>We will administer to both groups (healthy and T1D subjects) a high glycemic index meal enriched with butter</description>
    <arm_group_label>Butter-EVOO</arm_group_label>
    <arm_group_label>EVOO-Butter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age â‰¥ 18 years,&#xD;
&#xD;
          -  diagnosis of type 1 diabetes since at least 1 year,&#xD;
&#xD;
          -  HbA1c &lt;8.5% (69 mmol/mol),&#xD;
&#xD;
          -  stable insulin therapy for at least 3 months before the enrolment into the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy, celiac disease, history of cardiovascular diseases, hypertension,&#xD;
             hyperlipidemia, retinopathy, nephropathy, neuropathy, and ongoing treatment with&#xD;
             vasoactive drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Magna Graecia</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 12, 2021</study_first_submitted>
  <study_first_submitted_qc>March 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>March 20, 2021</last_update_submitted>
  <last_update_submitted_qc>March 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Magna Graecia</investigator_affiliation>
    <investigator_full_name>Concetta Irace</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Endothelial function</keyword>
  <keyword>FMD</keyword>
  <keyword>gastric emptying</keyword>
  <keyword>post prandial glycemia</keyword>
  <keyword>dietary fat</keyword>
  <keyword>EVOO</keyword>
  <keyword>butter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

